Savara (SVRA) Free Cash Flow (2010 - 2026)
Savara's (SVRA) quarterly Free Cash Flow came in at -$33.1 million in Q1 2026, down 21.73% year-on-year from -$42.3 million in Q1 2025, and down 32.09% on a QoQ basis from -$25.1 million in Q4 2025.
Savara (SVRA) Free Cash Flow (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Free Cash Flow data on file, last reported at -$33.1 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 21.73% year-over-year to -$33.1 million in Q1 2026; TTM through Mar 2026 was -$107.0 million, a 11.83% decrease from a year earlier, with the FY2025 full-year figure at -$101.1 million, down 13.41% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$33.1 million, down from -$25.1 million in the prior quarter.
- Over the last five years, Free Cash Flow for SVRA reached as high as -$8.2 million in Q3 2022 and fell as low as -$33.1 million in Q1 2026.
- Historically, Free Cash Flow has averaged -$18.2 million across 5 years, with a median of -$20.7 million in 2024.
- Across the five-year window, Free Cash Flow climbed 23.6% in 2022 and slumped 114.5% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$8.7 million in 2022, then slumped by 80.64% to -$15.6 million in 2023, then tumbled by 48.92% to -$23.3 million in 2024, then dropped by 7.68% to -$25.1 million in 2025, then slumped by 32.09% to -$33.1 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$33.1 million in Q1 2026, -$25.1 million in Q4 2025, and -$22.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | -33.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.10 Mn |
| Mar 31, 2026 | -33.10 Mn |
| Dec 31, 2025 | -25.06 Mn |
| Dec 31, 2025 | -25.06 Mn |
| Sep 30, 2025 | -22.53 Mn |
| Sep 30, 2025 | -22.53 Mn |
| Jun 30, 2025 | -26.28 Mn |
| Jun 30, 2025 | -26.28 Mn |
| Mar 31, 2025 | -27.19 Mn |
| Mar 31, 2025 | -27.19 Mn |
| Dec 31, 2024 | -23.27 Mn |
| Dec 31, 2024 | -23.27 Mn |
| Sep 30, 2024 | -22.67 Mn |
| Sep 30, 2024 | -22.67 Mn |
| Jun 30, 2024 | -22.52 Mn |
| Jun 30, 2024 | -22.52 Mn |
| Mar 31, 2024 | -20.65 Mn |
| Mar 31, 2024 | -20.65 Mn |
| Dec 31, 2023 | -15.63 Mn |
| Dec 31, 2023 | -15.63 Mn |